UBS AM
GOSS icon

UBS AM’s Gossamer Bio GOSS Stock Holding History

UBS AM’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-675
Closed -$117K – 2692
2022
Q4 		$117K Buy
675
+76
+13% +$50.1K ﹤0.01% 2485
2022
Q3 		$574K Hold
599
– – ﹤0.01% 2284
2022
Q2 		$401K Hold
599
– – ﹤0.01% 2383
2022
Q1 		$416K Hold
599
– – ﹤0.01% 2518
2021
Q4 		$542K Sell
599
-23
-4% -$21.9K ﹤0.01% 2521
2021
Q3 		$625K Hold
622
– – ﹤0.01% 2406
2021
Q2 		$404K Sell
622
-61
-9% -$42.3K ﹤0.01% 2594
2021
Q1 		$506K Buy
683
+152
+29% +$123K ﹤0.01% 2387
2020
Q4 		$411K Sell
531
-93
-15% -$73.3K ﹤0.01% 2352
2020
Q3 		$620K Buy
624
+86
+16% +$91.2K ﹤0.01% 2037
2020
Q2 		$560K Buy
538
+398
+284% +$400K ﹤0.01% 2070
2020
Q1 		$114K Buy
+140
New +$146K ﹤0.01% 2383

Other funds holding GOSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

UBS AM's GOSS Position: Q1 2023 in Review

UBS AM sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 675 shares — an estimated $117K sold.

UBS AM first reported a position in GOSS in Q1 2020 and held it in 12 quarters. The position peaked at $625K in Q3 2021. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • UBS AM reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • UBS AM sold 675 Gossamer Bio shares in Q1 2023, an estimated $117K.
  • UBS AM first reported a position in Gossamer Bio in Q1 2020 and held it in 12 quarters.
  • UBS AM's Gossamer Bio position peaked at $625K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.